![Substandard drugs: a potential crisis for public health - Johnston - 2014 - British Journal of Clinical Pharmacology - Wiley Online Library Substandard drugs: a potential crisis for public health - Johnston - 2014 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/2b3234ea-c2b0-4151-9570-86daccddcf02/bcp.2014.78.issue-2.cover.jpg?trick=1660222325355)
Substandard drugs: a potential crisis for public health - Johnston - 2014 - British Journal of Clinical Pharmacology - Wiley Online Library
![Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies - Journal of the American Academy of Dermatology Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5758f141-0abf-421c-8e43-a28abdfa207b/gr1_lrg.jpg)
Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies - Journal of the American Academy of Dermatology
![PDF) The authorization of non-biological complex drugs (NBCDs) follow-on versions: specific regulatory and interchangeability rules ahead? PDF) The authorization of non-biological complex drugs (NBCDs) follow-on versions: specific regulatory and interchangeability rules ahead?](https://i1.rgstatic.net/publication/257654935_The_authorization_of_non-biological_complex_drugs_NBCDs_follow-on_versions_specific_regulatory_and_interchangeability_rules_ahead/links/572b079208aef7c7e2c57056/largepreview.png)
PDF) The authorization of non-biological complex drugs (NBCDs) follow-on versions: specific regulatory and interchangeability rules ahead?
![JDMF 220MF10122 of Teva Czech Industries S. R. O. | Japan Drug Master Files | JP DMF | Pharmacompass.com JDMF 220MF10122 of Teva Czech Industries S. R. O. | Japan Drug Master Files | JP DMF | Pharmacompass.com](https://www.pharmacompass.com/image/banner/teva-api-june-2022gif-1656477879.gif?w=1200&h=630)